The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Klipsch and OJAS debut the kO-R2 at Milan Design Week 2026. Limited to 600 pairs total, with global availability expected in June. That matters more than the usual show-floor debut. The first kO-R1 ...

Left-handers are more competitive than right-handers, according to a new study published in the journal Scientific Reports. The findings may help explain why left-handedness has persisted throughout ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Ojas Partners founder Elam ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. LONDON — In the year-plus since ...

No matter how hard ideologues try to exclusively blame their political foes for acts of political violence, the truth is that violent extremists today emerge from across the political spectrum. We ...

There’s a popular idea that our brains have two sides with two roles. The left side of the brain is analytical and concerned with facts and figures, whereas the right side of the brain is creative, ...

Recursion Pharmaceuticals (RXRX) shares soared 5.8% in the last trading session to close at $5.84. The move was backed by solid volume with far more shares changing hands than in a normal session.

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. For decades, popular wisdom has held that left-handed people have a ...